EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?
Enhancer of zeste homolog 2 (EZH2), a histone methyltransferase, catalyzes tri-methylation of histone H3 at Lys 27 (H3K27me3) to regulate gene expression through epigenetic machinery. EZH2 functions as a double-facet molecule in regulation of gene expression via repression or activation mechanisms,...
Main Authors: | Ke-Sin Yan, Chia-Yuan Lin, Tan-Wei Liao, Cheng-Ming Peng, Shou-Chun Lee, Yi-Jui Liu, Wing P. Chan, Ruey-Hwang Chou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/18/6/1172 |
Similar Items
-
Up-regulated long non-coding RNA DUXAP8 promotes cell growth through repressing Krüppel-like factor 2 expression in human hepatocellular carcinoma
by: Jiang H, et al.
Published: (2019-09-01) -
EZH2 Down-Regulation Exacerbates Lipid Accumulation and Inflammation in in Vitro and in Vivo NAFLD
by: Serena Vella, et al.
Published: (2013-12-01) -
EZH2 Dynamically Associates With Non-coding RNAs in Mouse Hearts After Acute Angiotensin II Treatment
by: Shun Wang, et al.
Published: (2021-02-01) -
Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis
by: Sarah Brunty, et al.
Published: (2021-03-01) -
RIP-Seq of EZH2 Identifies TCONS-00036665 as a Regulator of Myogenesis in Pigs
by: Shanshan Wang, et al.
Published: (2021-01-01)